This inference can be reasonable because it was suggested that tumor budding, which is closely associated with EPCAM-PL, might be related to poor response to chemotherapy or chemoradiotherapy in CRC according to previous studies [15, 16]. This evidence concerns the gene EPCAM and colorectal carcinoma.